Literature DB >> 7874118

Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery.

C A Westbrook1, S J Chmura, R B Arenas, S Y Kim, G Otto.   

Abstract

Mutations or loss of the APC tumor-suppressor gene is important for the development of colorectal polyps and cancers, but little is known about the function of this gene in normal tissue. To study the role of APC and other genes in colonocytes in vivo, a system was developed whereby transient expression of genes is established in normal rodent colonic epithelium, using liposomal gene delivery by rectal catheter infusion. Expression of a beta-galactosidase reporter gene and of the human APC gene under a constitutive promoter is demonstrated. A high efficiency of transfection is maintained, with close to 100% of epithelial cells expressing the introduced gene. Expression is transient and does not persist beyond 4 days, consistent with the normal turnover time of gut epithelium, but it can be maintained by repeated treatments. Human APC was expressed for three weeks under these conditions at approximately one-tenth the level of the endogenous APC gene, and no toxicity was observed beyond that attributed to repeated rectal enemas. These results reveal that in vivo expression of exogenous gene is feasible using a liposomal delivery system and suggest a method to further study the physiologic role of APC or other genes in the interrelated process of colonic epithelial proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874118     DOI: 10.1093/hmg/3.11.2005

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  Current status of gene therapy in gastroenterology.

Authors:  Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

Review 2.  The promise of gene therapy in gastrointestinal and liver diseases.

Authors:  J Prieto; M Herraiz; B Sangro; C Qian; G Mazzolini; I Melero; J Ruiz
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 3.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 4.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

5.  Gene therapy in gastroenterology.

Authors:  H S Pandha; N R Lemoine
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

6.  Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure.

Authors:  S Wirtz; P R Galle; M F Neurath
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

7.  Liposome mediated gene transfer into the rat oesophagus.

Authors:  R M Schmid; H Weidenbach; G F Draenert; S Liptay; H Lührs; G Adler
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

8.  Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive.

Authors:  John I Lew; Yuee Guo; Richard K Kim; Lisa Vargish; Fabrizio Michelassi; Richard B Arenas
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Expression of the APC gene after transfection into a colonic cancer cell line.

Authors:  R Hargest; R Williamson
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

Review 10.  Inflammatory bowel disease: review from the aspect of genetics.

Authors:  Shunji Ishihara; M M Aziz; Takafumi Yuki; Hideaki Kazumori; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.